University of Pennsylvania Medical Center Guidelines for Antibiotic Use
|
Clinical Setting |
Empiric Treatment |
Likely Pathogens |
Definitive Treatment |
Dosage Regimen |
Duration |
|
Osteomyelitis1 | |||||
|
Normal Host |
nafcillin2 or cefazolin2 |
S. aureus |
nafcillin2 or cefazolin2 |
2gm IV q 4-6 hour 500mg IV q 8 hour |
6 weeks minimum, then continue until ESR normal3,4 |
|
|
Enterobacteriaceae (occasionally) |
TMP/SMX |
8-10mg/kg/day TMP IV/PO in 3-4 divided doses | ||
|
Intravenous Drug User |
vancomycin + gentamicin |
same as above + methicillin resistant S. aureus |
same as empiric (if culture data not available) |
gentamicin5 - see this link |
2 weeks |
|
vancomycin - see this link |
6 weeks minimum, then continue until ESR normal4 | ||||
|
Post-operative |
TMP/SMX |
S. aureus |
nafcillin2 or cefazolin2 |
2gm IV q 4-6 hour 500mg IV q 8 hour |
6 weeks minimum, then continue until ESR normal3,4 |
|
|
coagulase negative staphylococcus |
vancomycin | |||
|
Enterobacteriaceae |
TMP/SMX |
8-10mg/kg/day TMP IV in 3-4 divided doses | |||
|
P. aeruginosa |
piperacillin ± gentamicin |
4 gm IV q 6 hour | |||
|
Post- traumatic |
ampicillin/ sulbactam6 |
same as above, including: |
same as above |
same as above |
6 weeks minimum, then continue until ESR normal3,4 |
|
|
anaerobes (especially Clostridia spp.) |
penicillin G |
2mu IV q 4 hour | ||
|
Contiguous with decubitus ulcer/ diabetic foot |
TMP/SMX ± metronidazole7,8 |
polymicrobial |
same as empiric |
TMP/SMX 8-10mg/kg/day TMP IV in 3-4 divided doses metronidazole 500mg IV/PO q 12 hour |
6 weeks minimum, then continue until ESR normal3,4 |
1For optimal treatment, microorganism(s) should be identified by aspiration or bone biopsy; debridement will enhance cure rate
2If beta-lactam allergy use clindamycin or trimethoprim sulfamethoxazole; if MRSA-use vancomycin
3Should switch to oral therapy once clinical improvement occurs
4Use of ESR is controversial in this setting; if normal when therapy initiated, treat for 6 weeks
5Can switch to levofloxacin 500mg PO q 24 hour in combination with IV vancomycin
6Ampicillin/sulbactam dose=1.5gm IV q 6 hours
7Metronidazole: use if foul odor present
8Not for aggressive anaerobic infections in diabetic hosts
|
Clinical Setting |
Empiric Treatment |
Likely Pathogens |
Definitive Treatment |
Dosage Regimen |
Duration |
|
Septic Arthritis1 | |||||
|
Normal Host |
nafcillin2 or cefazolin2 |
S. aureus |
nafcillin2 or cefazolin2 |
2gm IV q 4-6 hour 500mg IV q 8 hour |
4-6 weeks3 |
|
|
Enterobacteriaceae |
TMP/SMX |
8-10mg/kg/day TMP IV in 3-4 divided doses | ||
|
group A streptococcus |
penicillin G |
8-12mu/d IV in 4-6 divided doses | |||
|
Sexually Active |
ceftriaxone |
N. gonorrhoeae |
ceftriaxone |
1gm IV q 24 hour |
7-10 days |
|
|
+doxycycline |
100mg PO BID | |||
|
then cefixime4,5 + doxycycline |
400mg PO q day 100mg PO BID | ||||
|
S. aureus |
same as above |
same as above | |||
|
Prosthetic Joint6 |
vancomycin + gentamicin |
coagulase negative staphylococcus |
vancomycin |
4-6 weeks7 | |
|
|
S. aureus |
nafcillin2 or cefazolin2 |
2gm IV q 4-6 hour 500mg IV q 8 hour | ||
|
P. aeruginosa |
piperacillin ± gentamicin |
4 gm IV q 6 hour | |||
|
Enterobacteriaceae |
TMP/SMX |
8-10mg/kg/day TMP IV in 3-4 divided doses | |||
1Complete drainage required for adequate therapy
2If beta-lactam allergy use clindamycin or trimethoprim/sulfamethoxazole; if MRSA-use vancomycin
3Should switch to oral therapy once clinical improvement occurs
4Should switch to oral therapy after 3 days of IV or IM therapy
5Cefixime is a non-formulary agent: a nonformulary request form must be completed
6Removal of prosthesis may be required
7May require subsequent oral therapy to eradicate infection
updated 9/28/04 by Lori LaRosa